Inovio Pharmaceuticals, Inc.
VACCINES AGAINST CORONAVIRUS AND METHODS OF USE

Last updated:

Abstract:

Disclosed herein are nucleic acid molecules encoding a SARS-CoV-2 spike antigen, SARS-CoV-2 spike antigens, immunogenic compositions, and vaccines and their use in inducing immune responses and protecting against or treating a Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection in a subject.

Status:
Application
Type:

Utility

Filling date:

25 Feb 2021

Issue date:

2 Sep 2021